1 asset in Spermatic Cord Cancer
Therapeutic assets addressing Spermatic Cord Cancer, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Eribulin Monomethanesulfonate Spermatic Cord Cancer | OHSU Knight Cancer Institute | P1 | CC (43) |